News related to
watch

In its stock exchange disclosure dated April 4, Tata Steel said the notice, dated March 30, alleges extraction of about 162.4 million tonnes of mineral coal beyond permissible limits during the period from FY2000-01 to FY2006-07. The company said the demand had been framed on grounds similar to those examined by the Supreme Court in the Common Cause versus Union of India litigation, a landmark case that hardened official scrutiny of mining done beyond environmental or statutory limits.

The scale and vintage of the claim are striking. By reaching back more than two decades, the notice underscores how historical mining records, clearances and production caps remain exposed to reinterpretation by regulators long after the ore or coal has been extracted. For Tata Steel, which has spent years simplifying its structure and strengthening its balance sheet while managing volatile steel demand, the notice also revives a regulatory risk investors know well: mining-linked liabilities that can surface suddenly and run into hundreds or thousands of crores.

Tata Steel has taken a firm line in response. In its filing, management said the claim “lacks justification and substantive basis” and indicated it would pursue legal remedies. That wording suggests the company does not see the notice as an immediately payable liability, but as a disputed demand that will have to be tested through litigation or administrative review. Bloomberg, citing the company statement, reported the amount at about $189 million.

The case fits into a wider pattern. Tata Steel’s annual reports already describe other significant Jharkhand mining disputes, including older claims tied to alleged unlawful iron ore extraction after the expiry of lease renewals. In those disclosures, the company said a demand of ₹3,568.31 crore had been challenged before the Jharkhand High Court, while another ₹421.83 crore notice had also been disputed and partly paid under protest after transit permits were halted. Tata Steel said in that filing that it believed it was remote the state’s demand would ultimately survive.

That history matters because it shows the latest notice is not an isolated compliance issue but part of a broader tension between mining companies and state authorities over how production limits, lease terms and environmental permissions should be interpreted. The Common Cause rulings sharpened the legal and financial consequences of excess extraction, especially where production outstripped environmental clearance or statutory approvals. Courts and regulators have since shown a greater willingness to revisit older conduct and calculate compensation on a far more punitive basis than companies had anticipated years ago.

For Jharkhand, one of the country’s key mining belts, such claims carry a dual message. They show the state remains determined to pursue compensation linked to alleged over-extraction, while also signalling to miners that legacy operations are not beyond review. For the industry, the episode is another reminder that captive mines, often central to cost control for steelmakers, bring legal and policy exposure alongside raw material security. The business logic of owning mineral assets remains strong, but it comes with increasingly intense compliance scrutiny.

The timing is also notable. Tata Steel has faced other mining-related claims over the past year, including a demand from Odisha in July 2025 linked to mineral dispatch issues at the Sukinda Chromite Block. While the factual basis of that case differs from the West Bokaro matter, the accumulation of notices across jurisdictions suggests large resource companies remain under close watch from state mining departments even as policymakers push for higher domestic output of minerals and metals.

South Korea’s consumer prices rose 2.2 per cent in March from a year earlier, quickening from 2.0 per cent in both January and February as higher energy costs fed through the economy and kept inflation above the Bank of Korea’s medium-term 2 per cent target. The increase was milder than market expectations for 2.4 per cent, but it still marked the fastest annual pace since December and underscored the strain created by elevated crude prices linked to conflict-driven instability in the Middle East.

On a monthly basis, consumer prices rose 0.3 per cent in March, matching February’s pace. Petroleum products were a major driver even after Seoul introduced emergency measures to curb the blow to households and businesses. Government controls on fuel prices helped limit the pass-through, yet petroleum product prices still rose sharply from the previous month, showing how external energy shocks are overpowering domestic stabilisation efforts.

The inflation print matters because it lands at a moment when policymakers are trying to balance stronger export-led growth against mounting imported price pressures. The Bank of Korea said in its February outlook that consumer-price inflation for 2026 was expected to average 2.2 per cent, slightly above its previous 2.1 per cent forecast. That projection was made before the latest oil surge intensified, leaving economists to question whether the central bank’s assumptions have already been overtaken by events.

Core inflation, which strips out volatile food and energy items, eased slightly to 2.2 per cent in March from 2.3 per cent in February. That suggests underlying domestic demand pressures remain contained, even as headline inflation is being pushed up by imported costs. Another closely watched measure, which excludes agricultural products and petroleum, had been running at 2.5 per cent in February, indicating that sticky service-sector and household spending components have not fully disappeared.

Food prices offered some relief. Agricultural product prices fell in March as supply conditions improved, helping offset part of the jump in fuel-linked costs. That softer food picture helped explain why the overall figure came in below forecasts despite the energy shock. Still, analysts say the cushion from better farm output may prove temporary if transport, fertiliser and logistics costs keep climbing with oil.

South Korea is especially exposed because of its dependence on imported energy. About 70 per cent of its crude oil imports come from the Middle East, leaving the country vulnerable whenever shipping routes or production in the region come under threat. The government has already floated wider demand-management steps, including possible driving curbs beyond the public sector if crude prices climb further, a sign of how seriously officials are treating the supply risk.

Seoul has also moved on the fiscal side. This week the government proposed a supplementary budget of 26.2 trillion won, or about $17.3 billion, aimed at cushioning the economy from the oil shock and supporting low-income households and affected businesses. Of that, 10.1 trillion won is earmarked for measures tied to surging oil prices, including support for refiners operating under the emergency pricing system. The package highlights concern that inflation and slower consumption could combine to weaken the broader recovery.

For the central bank, the March data complicate an already delicate policy setting. The Bank of Korea’s next rate decision is due on April 10. Policymakers had held rates steady in February, and the latest inflation reading, while lower than forecast, is unlikely to offer much comfort because upside risks remain tied to oil, the exchange rate and transport costs. At the same time, softer core inflation argues against an aggressive response unless the energy shock broadens into wages and services.

The proposed tender offer price is ¥4,750 a share. That figure carries an unusual wrinkle: Reuters reported it stood 4.7% below Taiyo’s last closing price, reflecting how market speculation had already lifted the stock, while the joint company release framed the offer as carrying a steep premium to unaffected average prices before the bidding process became public and before activist-related filings stirred the shares. The contrast underlines how Japan’s take-private deals are increasingly playing out in markets already primed by rumour, activism and expectations of strategic change.

Taiyo is not a household consumer name, but it sits in businesses that have become more visible to global investors. The group is a leading producer of solder resist and other materials used in printed circuit boards and semiconductor packaging substrates, while also operating a medical and pharmaceutical arm that makes prescription drugs and provides contract development and manufacturing services. In its own long-term planning, Taiyo has pointed to growth opportunities from generative AI, data centres and communications infrastructure on the electronics side, alongside structural reform and expansion in contract manufacturing for pharmaceuticals.

That mix helps explain why KKR sees room for a private-market strategy. Taiyo said privatisation would allow it to pursue long-term investments and quicker decision-making with less pressure from the public market. The company’s “Beyond Imagination 2030” plan targets a rise in net sales to ¥180 billion by fiscal 2031 from ¥119 billion in fiscal 2025, while operating income is targeted to more than double to ¥47 billion from ¥22 billion. Management has also been trying to improve capital efficiency after sustained dialogue with shareholders, including a focus on profitability in the medical and pharmaceuticals unit and a review of portfolio positioning across the group.

For KKR, the Taiyo bid fits a broader pattern in Japan. The firm said it has been investing in the country for two decades and manages more than $20 billion there. Its existing investments span semiconductor equipment, pharmaceuticals, information technology and logistics, sectors where global funds have been seeking companies with specialised technology, export potential or scope for operational overhaul. Taiyo gives KKR exposure to electronics materials tied to advanced manufacturing as well as a pharmaceuticals platform that could benefit from demand for contract manufacturing and stable domestic drug supply.

The shareholder line-up behind the offer is also notable. DIC, Taiyo’s largest shareholder, and Kowa, which is affiliated with the founding family, have agreed to sell through a share consolidation and buyback process after the tender offer is completed. The founding family plans to reinvest in the KKR-managed vehicle that will own Taiyo after privatisation. Oasis Management, long known for active positions in Japan, has separately agreed to tender shares representing about 15.62% of the company. That combination reduces execution risk and suggests the deal has been designed to balance continuity with outside capital and governance pressure.

Still, the transaction comes with questions that investors and analysts will watch closely. A take-private at a headline valuation above ¥500 billion will invite scrutiny over whether minority holders are being offered enough upside after the stock’s sharp re-rating. The tender offer has yet to begin formally and remains subject to customary conditions, including regulatory approvals. Any delays or shifts in market conditions could test sentiment, especially at a time when deal financing and foreign buyouts in Japan are being judged against a higher bar on governance, transparency and shareholder treatment.

Taiyo’s business profile gives the story wider significance than a conventional chemicals buyout. Its electronics arm remains the core earnings driver, but the medical and pharmaceuticals business has been gaining attention as order volumes rise in contract manufacturing and as the group tries to lift margins. Taiyo’s own targets show electronics sales climbing to ¥128 billion by fiscal 2031 and medical and pharmaceuticals sales to ¥43 billion, with the latter expected to deliver a marked improvement in profitability. That combination of steady industrial demand and a healthcare growth angle is the sort of hybrid case private equity firms have been seeking across Japan’s listed mid-cap sector.

Responding to Hong Kong’s aging trend Extending “retirement planning” into “health capital management”

HONG KONG SAR – Media OutReach Newswire – 1 April 2026 – As one of the world‘s longest-living regions, Hong Kong is increasingly focused on how to plan for the second half of life and improve the quality of life for older adults. As artificial intelligence rapidly enters healthcare and elderly care, preventive medicine is becoming the next key issue for Hong Kong‘s aging society. LIVE4WELL will debut Hong Kong‘s most comprehensive AI health management experience zone at the “Smart Retirement Expo” (Booth: Hall 1E C01-2, 05-08), combining multiple clinical-grade technologies and generating personalized health reports in real time, allowing the public to experience first-hand how AI is reshaping “health capital management.”

The exhibition will be held grandly from 3 to 5 April 2026 at the Hong Kong Convention and Exhibition Centre, Hall 1E, and is expected to attract more than 100,000 visitors, offering the public one-stop retirement planning and healthy living solutions.

Medical-grade, non-invasive smart health checks
Professional consultants will explain reports on site

During the expo, LIVE4WELL will offer the most comprehensive AI health assessment experience in Hong Kong. Visitors may choose two free tests, each taking about 5 to 10 minutes:

• AI fondus analysis: Uses retinal imaging to analyze microvascular and nerve changes to predict cardiovascular and metabolic disease risk.
• 3D posture structure assessment: No wearable device required; AI motion-capture technology evaluates postural imbalance, muscle coordination, and pain triggers.
• Body composition analysis: Analyzes skeletal muscle mass, body fat percentage, and tendency toward sarcopenia.
• New: Medical-grade body measurement: Uses inflammation indicators to analyze bodily function and chronic risk status in depth.
• New: Electrical impedance tomography (special trial price): Assesses the risk index for chronic liver and kidney diseases.

After the tests, professional health consultants will explain the personalized health report on site, transforming complex medical data into simple, practical lifestyle advice, helping the public truly practice “prevention is better than cure.” LIVE4WELL recommends regular testing every three months to monitor health status; if any concerns arise, users can seek solutions from a professional medical team and receive treatment early. In addition, LIVE4WELL‘s partners include Chubb Life Hong Kong, Trinity Medical Centre, E-SENSE Innovative Technology Company, Clarity Eye Centre, KAM HearingHealth HK, and LINK2CARE‘s smart watch combining “Chinese prevention” and “Western treatment.” During the expo, they will offer limited-time discounts on products and services that support health protection.

Event details
Exhibition name: Smart Retirement Expo
Dates: 3–5 April 2026
Time:

• 3–4 April (Fri–Sat): 10:00 a.m. – 8:00 p.m.
• 5 April (Sun): 10:00 a.m. – 6:00 p.m.

Venue: Hong Kong Convention and Exhibition Centre, Wan Chai, Hall 1E
LIVE4WELL Booth: C01-2, 05-08 (54 sq. m.)
LIVE4WELL Seminar: AI Reveals Health Risks: 20 Minutes to Understand the Truth Behind Risk
Hall 1E Leisure Zone

3 April (Fri), 1:10–1:30 p.m.
Ms. Miranda Wong, Co-Founder

Media invitation
LIVE4WELL warmly invites media friends to visit the booth during the exhibition for coverage. Arrangements can include:

• Interviews with the founding team and technical experts
• Filming demonstrations of the AI testing process
• On-site interviews with members of the public experiencing the service
• Feature sharing on preventive medicine and senior health

Hashtag: #LIVE4WELL

The issuer is solely responsible for the content of this announcement.

About LIVE4WELL

LIVE4WELL is a health management platform driving a new era of preventive medicine for all through artificial intelligence. Using clinical-grade testing devices from multiple countries, AI data analysis, and a mobile app, it creates a complete health loop of “testing, understanding, action, tracking, reward.” LIVE4WELL‘s goal is not merely to build a health app, but to establish a technology-driven, people-centered, practical preventive healthcare ecosystem that creates a better future for public health.

01 | Three improvement solutions from smart diagnosis to action

Based on users‘ test results, risk assessment, and lifestyle, the platform provides practical improvement plans, including:

• Dietary adjustments: personalized meal suggestions adapted to local food culture
• Nutritional supplementation: data-driven guidance to avoid blind use of health supplements
• Exercise prescriptions: from walking and stretching to functional training, emphasizing safety and sustainability

02 | Data-driven intelligent interpretation as a “personalized health manual”

LIVE4WELL creates a customized, user-centered health report for each participant, integrating multi-source test results and presenting them visually with risk grading and plain-language explanations, becoming a truly actionable “personalized health manual.” The platform integrates large language models across multiple medical specialties, combining clinical literature and preventive medicine research, with professional input from medical experts and university scholars.

03 | Eight training systems and an all-day digital ecosystem

LIVE4WELL has uniquely developed eight training systems, covering:
cardiorespiratory endurance | muscular strength and endurance | balance and stability | flexibility and joint mobility | posture and spine health | metabolism and weight management | stress and sleep regulation | functional daily living training.

The mobile app turns offline testing into a 24-hour online nutritionist and fitness coach, integrating meal tracking, calorie tracking, step monitoring, and personalized tasks.

04 | Sweat Point™ rewards and social ecosystem

The platform features a Sweat Point™ wallet rewards system and the WELLShop™ healthy consumption platform. After completing health tasks, reaching step goals, or joining community activities, users can earn “exercise miles” to redeem health products. Social features also encourage families and friends to join challenges together, making health management a shared and encouraging social activity.

05 | Digital infrastructure for public policy

LIVE4WELL‘s vision is to become the next-generation digital infrastructure deeply integrated with public healthcare policy. Through anonymized health data, it can help decision-makers:

• Improve health education and public exercise policy
• Allocate medical resources more precisely
• Open new employee health management models for corporations and insurers

This makes “just move a little every day” not just a slogan, but a lifestyle path everyone can practice. When everyone takes responsibility for their own health, overall social well-being, productivity, and future competitiveness will also rise.

More information, please visit：www.live4well.io